Status: Active
Distalmotion
- Status Current
- Sector Medical Robotics
- Year Invested 2022
- HQ Epalinges, Switzerland
- Clinical Operations Germany, Switzerland, France
- Lead Partner Frederik Groenewegen
Website www.distalmotion.com/
Related News
- Distalmotion Gains FDA 510(k) Clearance for Cholecystectomy, Further Advancing Access to Robotics in the Outpatient Setting with its DEXTER® Robotic Surgery System
- Distalmotion Completes First US Sale of its DEXTER® Robotic Surgery System to Memorial Hermann Health System
- FDA Grants De Novo Marketing Authorization for the Distalmotion Dexter® Surgical Robot
- Robotic Surgery pioneer Distalmotion partners with Proximie to extend surgical excellence globally
- Distalmotion raises $150M to accelerate FDA Approval and Clinical Experience
- Distalmotion Raises $90M to Accelerate Adoption of Surgical Robot Dexter
On-Demand, Open Platform Robotic Surgery
Commercial-stage company pioneering on-demand surgical robotics. The company’s Dexter robotic platform allows hospitals and surgeons to benefit from the best of all worlds in surgical robotics and laparoscopy.